ArticleInternal medicine (Tokyo, Japan)2022

Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan.

Takayuki Fujii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.